Profound Medical PROF Foreign currency translation gains (losses)
Foreign currency translation gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Profound Medical in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's foreign currency translation gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Profound Medical's foreign currency translation gains (losses)?
- Profound Medical (PROF) reported foreign currency translation gains (losses) of -$1.01M in Q1 2026.
- How has Profound Medical's foreign currency translation gains (losses) changed year-over-year?
- Profound Medical's foreign currency translation gains (losses) decreased by 1075.7% year-over-year, from $103K to -$1.01M.
- What is the long-term trend for Profound Medical's foreign currency translation gains (losses)?
- Over 2 years (2023 to 2025), Profound Medical's foreign currency translation gains (losses) has grown at a 88.3% compound annual growth rate (CAGR), from $644K to $2.28M.
- What does foreign currency translation gains (losses) mean?
- This metric captures the gains or losses arising from the translation of financial statements of foreign subsidiaries from their functional currency into the reporting currency of the parent company. It reflects the impact of exchange rate fluctuations on the value of international assets and liabilities. This figure is excluded from net income and is instead reported as a component of equity to show the volatility of global operations.